Archive · 28 Jul 2025
India's Drug Price Regulator to Monitor Non-Essential Medicine Costs
The government is watching how much the price of medicines that aren't usually controlled goes up.
Companies can only raise the price of these medicines by a little bit each year, to help people afford them.
If companies break the rules and charge too much, they will have to pay back the extra money.
The government is doing this to make sure healthcare is affordable and stop companies from making too much profit on medicine.
NPPA will monitor price increases of non-scheduled drugs.
Manufacturers can only increase the MRP by a maximum of 10% annually.
The directive aims to ensure affordable healthcare for consumers.
Companies must align prices of non-scheduled formulations under different brands.
Violations may result in penalties, including fines and repayment.
- Who
- The National Pharmaceutical Pricing Authority (NPPA) and pharmaceutical manufacturers.
- What
- NPPA will monitor the prices of non-scheduled drugs.
- When
- The directive was issued on July 22nd.
- Where
- India.
- Why
- To ensure drug prices are controlled and healthcare remains affordable.
Consumers/Government
Pharmaceutical Industry
Pricing Policies
Consumers/Government
Enforcement ensures that medicine costs stay reasonable.
Pharmaceutical Industry
Industry may face challenges with pricing adjustment.
- Authority
- National Pharmaceutical Pricing Authority (NPPA)
- Regulation
- Drugs Price Control Order (DPCO), 2013
- Annual Price Increase Limit
- 10%
- Action
- Alignment of Prices under Different Brands
- Penalty
- Fines and overcharged amount return with interest